Do these calculators replace comprehensive geriatric assessment?

No. They support risk discussion and triage but should be interpreted with functional, cognitive, nutritional, social, comorbidity, regimen, and patient-goal context.

Is G8 a chemotherapy toxicity calculator?

No. G8 is a geriatric screening tool that helps identify older adults who may benefit from comprehensive geriatric assessment. It does not estimate grade 3-5 chemotherapy toxicity by itself.

Clinical Tools

July 3, 2026

OncoToolkit Team

Geriatric Oncology Toxicity Calculators

Q: When is CARG-BC preferred over CARG?

CARG-BC is preferred when the patient is age 65 or older with stage I-III breast cancer receiving neoadjuvant or adjuvant chemotherapy and the required breast-specific inputs are available.

Compare G8, CARG, CARG-BC, CRASH, and Charlson tools for older adults being considered for chemotherapy.

Evidence-Based Guide

Geriatric oncology toxicity calculators comparison

Quick Navigation

1. Why This Cluster Matters

Older adults with cancer vary widely in physiologic reserve, cognition, mobility, nutrition, social support, renal function, and treatment goals. Chronologic age and ECOG performance status alone often miss vulnerabilities that affect chemotherapy tolerance. ASCO and geriatric oncology guidance therefore emphasize structured geriatric assessment and validated tools to identify risks that routine oncology assessment may not capture.¹, ²

OncoToolkit now groups several complementary geriatric oncology calculators: G8, CARG, CARG-BC, CRASH, and Charlson. They answer related but different questions. The safest use is to define the clinical question first, then choose the tool that matches the patient population and decision point.

Clinical caution

These scores support risk communication and care planning. They do not decide whether chemotherapy is "allowed," and they should not replace geriatric assessment, oncology judgment, pharmacy review, or patient priorities.

2. Quick Links

3. Tool Comparison

Tool	Best Use	Output	Notes
G8	Screening for geriatric vulnerability before cancer treatment	Normal vs abnormal screen	Fast triage tool; abnormal results support fuller geriatric assessment.³
CARG	Older adults starting chemotherapy across cancer types	Grade 3-5 toxicity risk group	Practical, widely used, and easier to collect than CRASH in many clinics.⁴
CARG-BC	Adults 65 or older with stage I-III breast cancer receiving neoadjuvant/adjuvant chemotherapy	Breast-specific grade 3-5 toxicity risk	Prefer over general CARG for this specific population when inputs are available.⁵
CRASH	Older adults where Chemotox, hematologic, and nonhematologic predictors are available	Combined score plus hematologic and nonhematologic subscore context	More detailed; Chemotox category should be chosen carefully, ideally with oncology pharmacy input.⁶
Charlson	Comorbidity burden and mortality-risk context	Weighted comorbidity score	Not a chemotherapy toxicity score by itself.

Risk Bands to Keep Straight

Calculator	Low	Intermediate	High
CARG	0-5 points, about 30% toxicity	6-9 points, about 52% toxicity	10-19 points, about 79%-83% toxicity
CARG-BC	0-5 points, about 27% toxicity	6-11 points, about 45% toxicity	12 or more points, about 76% toxicity
CRASH	0-3 combined score	4-6 intermediate-low; 7-9 intermediate-high	>9 combined score

4. Practical Workflow

Start with the treatment question. Is the visit about vulnerability screening, chemotherapy toxicity prediction, breast-specific adjuvant therapy, or comorbidity context?
Screen for vulnerabilities early. Use G8 when the first question is whether a patient needs a fuller geriatric assessment.
Estimate toxicity before finalizing chemotherapy. Use CARG for broad chemotherapy toxicity discussion, or CARG-BC for older adults with early-stage breast cancer receiving neoadjuvant or adjuvant chemotherapy.
Use CRASH when the required details are reliable. The CRASH score separates hematologic and nonhematologic predictors, but it depends on a defensible Chemotox category and additional geriatric measures.
Add comorbidity context. Use the Charlson Comorbidity Index to describe comorbidity burden, while remembering it is not a direct chemotherapy toxicity model.
Turn the score into an intervention plan. High-risk results should prompt medication review, falls planning, nutrition support, renal dosing review, social support planning, physical therapy, closer monitoring, or regimen modification when clinically appropriate.

5. Clinical Scenarios

New metastatic colorectal cancer consultation, age 78

Use G8 to identify vulnerabilities, then CARG to estimate grade 3-5 chemotherapy toxicity before choosing intensity. Add renal function, neuropathy risk, DPYD/DPD context when relevant, and goals-of-care discussion.

Stage II breast cancer, age 72, considering adjuvant chemotherapy

Use CARG-BC when required inputs are available because it was developed for older adults with stage I-III breast cancer receiving neoadjuvant or adjuvant chemotherapy. Pair toxicity risk with recurrence benefit tools and patient priorities.

Complex regimen review before tumor board

CRASH may be helpful when the team can assign Chemotox carefully and collect IADL, LDH, ECOG, MMSE, and MNA. If those inputs are uncertain, document the uncertainty rather than presenting a false-precision score.

6. FAQ

Which geriatric oncology toxicity calculator should I use?

Use CARG for general older-adult chemotherapy toxicity, CARG-BC for older adults with early-stage breast cancer receiving chemotherapy, CRASH when its regimen and geriatric inputs are reliable, and G8 when the question is screening for vulnerability.

Do these tools replace comprehensive geriatric assessment?

No. They help prioritize risk discussion and interventions, but comprehensive assessment remains important for function, cognition, nutrition, falls, mood, polypharmacy, social support, and goals.

Can a high-risk score be used to deny chemotherapy?

No. A high-risk score should trigger a careful conversation about benefit, alternatives, dose intensity, supportive-care interventions, and patient priorities. It should not be used as a stand-alone exclusion rule.

Choose the Right Geriatric Oncology Tool

Screen vulnerability, estimate toxicity, and document supportive-care needs before chemotherapy starts.

Open Supportive Care Calculators

References

Mohile SG, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. PMC
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update. ASCO
Bellera CA, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012. PubMed
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2011. PMC
Magnuson A, et al. Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer. J Clin Oncol. 2021. PMC
Extermann M, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012. PubMed
Prospective comparison of the value of CRASH and CARG toxicity scores in older adults. PMC

Saved Results